Researchers & Healthcare Professionals

www.lls.org/researchershealthcareprofessionals

Did you know?

LLS Therapy Acceleration Program partner, Avila Therapeutics, has initiated a phase 1 study of AVL-292, a targeted covalent drug for B cell cancers and autoimmune diseases.

CLL- Understanding Diagnosis and Treatment

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: February 28, 2012
CE Credit Available Until: November 23, 2013
Location: Telephone/Web
Target Audience: Oncology nurses and social workers involved in the treatment of CLL.
Read: CLL Spotlight | Transcript | Program Slides
Listen: Presentation | Q&A Session
Access: Virtual Lecture

Activity Purpose

To educate oncology nurses and social workers about chronic lymphocytic leukemia (CLL) diagnosis and treatment.

Educational Objectives

At the conclusion of this program, participants should be able to:

  • Describe tests used to diagnose and stage CLL
  • Identify current and emerging treatments for CLL patients
  • Explain personalized CLL treatment plans
  • Describe the importance of clinical trials in improving CLL patient outcomes
  • Discuss CLL side effects management and quality of life 

Speaker

Michael J. Keating, MB, BS
Professor of Medicine and Internist
Leukemia Department
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX

Questions Asked by the CLL Community

  • How routinely are diagnostic tests done for CLL patients and are they just happening at research institutions or are community oncologists also using them?
  • When is the appropriate use of stem cell transplantation?
  • What are the side effects of long-term maintenance using rituximab (Rituxan®) only?
  • Could you discuss why the military has chosen to cover certain agents or occupations that may be associated with causing CLL?
  • After relapse, why is it preferred to wait for more symptoms before treatment?
  • Is there a connection between multiple myeloma and CLL?
  • Is treatment an option for patients who have other health issues such as heart problems or diabetes?
  • If a child has Crohn's disease, could that be because the parent has CLL?
  • How often should you have a fluorescence in situ hybridization (FISH) test done?
  • How long is it possible to go without getting treatment?      
  • Are there any common CLL treatments that would be of interest to a large granular lymphocytic leukemia (LGL) patient?
  • What is the risk of developing other health issues or other cancers from CLL treatment?
  • How do you see gene therapy coming into play with regards to CLL treatment in the future?

Sponsors and Supporters

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Teva Oncology.

last updated on Friday, November 30, 2012
btn_sharethis

Publications

Publications

A free resource provided by the National Institutes of Health - access more than 20 million biomedical literature citations.

Learn More